UNSPSC 51172478: Omeprazole/sodium bicarbonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA900. This VA Drug Class (GA900) classifies this compound as belonging to the group GASTRIC MEDICATIONS, OTHER.

UNSPSC 51172478 Omeprazole/sodium bicarbonate is a Commodity code that in practice covers pharmaceutical products and testing services solicited across state and local government health, corrections, and purchasing coordination operations. Recent state and local opportunities under this code show a divergence between the code's nominal scope—a specific gastrointestinal medication—and the actual work being procured, which spans drug-testing infrastructure, direct-to-manufacturer pharmacy programs, and multi-source generic pharmaceuticals and OTC products. Issuing bodies include county corrections departments, state health and human services commissions, and multistate cooperative purchasing alliances. The code reflects activity in correctional specimen collection and testing, state pharmacy benefit management, and cooperative purchasing coordination across multiple jurisdictions.

Geographic activity centers on Texas and Minnesota with multistate reach. Collin County Community Supervision and Corrections Department in Texas posted an RFP (2026-327) due July 23, 2026 for offender specimen collection and drug testing services covering two collection sites in Plano and McKinney with an estimated contract value of $600,000 over two years plus three optional one-year renewals. Texas Health and Human Services Commission issued an RFI (HHS0017013) in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs for state pharmacy benefit optimization. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted an RFP (S1070000015802) due March 26, 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across state and local government facilities in Minnesota and Oregon, with contract effectiveness July 1, 2026. The code shows minimal recent activity directly tied to omeprazole/sodium bicarbonate itself; procurement under this code is driven by broader pharmacy benefit and drug-testing service acquisition rather than single-product specification.